Twist Bioscience's proprietary silicon-based DNA manufacturing platform is driving double-digit revenue growth and margin expansion, positioning the synthetic biology tools provider on a clear path to adjusted EBITDA breakeven by fiscal 2026.
Global equities and commodities staged a broad recovery on Tuesday, shaking off a pan-Asian rout triggered by a hawkish Fed nominee and geopolitical jitters. The rebound was anchored by surprisingly strong US manufacturing figures, offering a respite to bruised investors.
French biotech Abivax sees renewed investor interest following strong Phase 3 data for its oral therapy obefazimod in hard-to-treat ulcerative colitis, with analysts pointing to a clear path to regulatory approval and significant market potential.
Cronos Group's stock has rallied on renewed optimism for U.S. cannabis reform. We examine the regulatory shift, strategic positioning, and long-term potential driving investor sentiment.
Venture Global LNG, a polarizing leader in U.S. gas export infrastructure, trades at a deep discount despite record operational performance. This analysis explores the bull case for the stock, which hinges on resolving multibillion-dollar legal disputes and capitalizing on soaring global LNG demand.
The Malaysian marine construction firm Benalec Holdings Berhad is showing early signs of a financial turnaround, with its key profitability metric moving into positive territory after years of losses. While its return on capital remains modest, the trend suggests improved capital allocation.
Asian equities and Bitcoin stabilized Tuesday following a turbulent session, with investors digesting a rebound in US factory data and a calmer precious metals market. Regional indexes recovered, while crypto markets assessed the damage from recent liquidations.
Amid rising global tensions and sustained U.S. defense spending, Lockheed Martin's unique role in stitching together America's missile and space defense architecture presents a compelling investment case, analysts argue.
Elon Musk's SpaceX is set to acquire his artificial intelligence startup xAI in a landmark share exchange, with investors offered 0.1433 SpaceX shares for each xAI share, according to a source familiar with the transaction. The deal underscores Musk's strategy of consolidating his tech empire amid fierce AI competition.
While positioned at the forefront of the small modular reactor (SMR) revolution, NuScale Power remains a pre-revenue manufacturer with significant hurdles to clear before it can deliver on its potential as a growth—and eventual dividend—story for investors.
Johnson & Johnson's oncology portfolio gains momentum with new clinical data for prostate cancer drug Erleada and a broader FDA label for multiple myeloma therapy Darzalex Faspro, reinforcing its competitive stance in key cancer markets.
SanDisk (NASDAQ: SNDK) and Kioxia have renewed their flash memory joint venture for another five years, a strategic move aimed at securing advanced 3D NAND production capacity and supply chains through 2034 to meet the explosive storage needs of artificial intelligence.
Former President Bill Clinton and former Secretary of State Hillary Clinton have agreed to provide depositions to the House Oversight Committee, following the panel's move to hold them in criminal contempt of Congress over the Jeffrey Epstein investigation.
Elon Musk announces the integration of his AI startup xAI into SpaceX, citing terrestrial power and cooling constraints as a catalyst for moving advanced computing into space, with the Starship program central to the ambitious orbital data center vision.
As AI agents flock to a dedicated social platform, creating their own cultures and discussing independence, tech billionaire Bryan Johnson warns of unforeseen consequences, comparing the phenomenon to a mirror of humanity's own impulses.
Cipher Mining Inc. (CIFR), once a traditional cryptocurrency miner, has rapidly transformed into a key developer of industrial-scale data centers, capitalizing on the insatiable power demands of artificial intelligence. With a portfolio exceeding 3 gigawatts, primarily in power-rich West Texas, the company is now building the physical backbone for tech giants. This strategic pivot, however, raises critical questions about capital allocation and the sustainability of the AI infrastructure rush.
Former President Bill Clinton and former Secretary of State Hillary Clinton have reversed course and agreed to provide testimony to the House Oversight Committee's investigation into Jeffrey Epstein, following the panel's move to hold them in contempt.
As AI infrastructure scales, reliability becomes paramount. Credo Technology Group, once a niche connectivity player, is now seeing explosive growth as its solutions become critical to preventing costly failures in hyperscale data centers. With revenue soaring over 270% and margins expanding, the debate is whether Credo is a cyclical beneficiary or the foundational 'toll road' of modern AI computing.
Former President Bill Clinton and former Secretary of State Hillary Clinton have agreed to provide depositions to the House Oversight Committee, in a last-minute move to avert a congressional contempt vote scheduled for this week.
While surging data center demand promises growth for utilities like AEP, a critical 'transmission gap' and rising regulatory scrutiny pose significant risks to execution and future cash flows, challenging the current bullish narrative.
